Hanley David A, Davison K Shawn
Division of Endocrinology and Metabolism, Departments of Medicine and Oncology, University of Calgary Faculty of Medicine, Calgary, Alberta, Canada.
J Nutr. 2005 Feb;135(2):332-7. doi: 10.1093/jn/135.2.332.
Vitamin D insufficiency is a term that has been used to describe the finding of biochemical evidence of deficiency, without obvious clinical signs or symptoms, such as rickets or osteomalacia. The condition is most commonly diagnosed by a serum 25-hydroxyvitamin D below 40 nmol/L (16 microg/L). This paper reviews North American studies addressing the prevalence of the problem, and the growing body of evidence that vitamin D insufficiency predisposes individuals to poor bone and muscle health. The term insufficiency is somewhat misleading, as patients with this condition are really just part of the spectrum of vitamin D deficiency. If the more generous definition of this condition is used (serum 25-hydroxyvitamin D < 80 nmol/L), a much larger proportion of the population has the problem. The response to vitamin D supplementation in clinical trials suggests current recommendations for dietary intake of this vitamin are too low and that a higher adequate intake should be recommended.
维生素D不足是一个用于描述缺乏生化证据,但无明显临床体征或症状(如佝偻病或骨软化症)的术语。这种情况最常见的诊断依据是血清25-羟维生素D低于40 nmol/L(16 μg/L)。本文综述了北美关于该问题患病率的研究,以及越来越多的证据表明维生素D不足会使个体易患骨骼和肌肉健康问题。“不足”这个术语有点误导性,因为患有这种情况的患者实际上只是维生素D缺乏范围的一部分。如果采用对这种情况更宽松的定义(血清25-羟维生素D < 80 nmol/L),那么有问题的人群比例会大得多。临床试验中对维生素D补充剂的反应表明,目前对这种维生素膳食摄入量的建议过低,应该推荐更高的适宜摄入量。